374 related articles for article (PubMed ID: 18783531)
41. The testosterone patch for women.
Kingsberg SA
Int J Impot Res; 2005; 17(5):465-6. PubMed ID: 16049522
[TBL] [Abstract][Full Text] [Related]
42. A 'magic bullet' for a lackluster libido? The newly approved Addyi is not yet ready for prime-time women.
Health After 50 Sci Am Consum Health; 2015 Dec; 27(12):1-2. PubMed ID: 27062743
[No Abstract] [Full Text] [Related]
43. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
Reis SL; Abdo CH
Clinics (Sao Paulo); 2014; 69(4):294-303. PubMed ID: 24714838
[TBL] [Abstract][Full Text] [Related]
44. Testosterone for the treatment of hypoactive sexual desire disorder: part II.
Feldhaus-Dahir M
Urol Nurs; 2009; 29(5):386-9, 378. PubMed ID: 19863046
[TBL] [Abstract][Full Text] [Related]
45. The Hypoactive Sexual Desire Disorder Registry to characterize the natural history and outcomes of women with hypoactive sexual desire disorder.
Kingsberg SA
Menopause; 2012 Apr; 19(4):379-81. PubMed ID: 22453129
[No Abstract] [Full Text] [Related]
46. Testosterone use in postmenopausal women.
Martínez-García A; Davis SR
Climacteric; 2021 Feb; 24(1):46-50. PubMed ID: 32705895
[TBL] [Abstract][Full Text] [Related]
47. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
[TBL] [Abstract][Full Text] [Related]
48. Management of hypoactive sexual desire disorder.
Segraves RT
Adv Psychosom Med; 2008; 29():23-32. PubMed ID: 18391555
[TBL] [Abstract][Full Text] [Related]
49. Medicalization of women's sexual problems: a different story?
Graham CA
J Sex Marital Ther; 2007; 33(5):443-7. PubMed ID: 17674225
[No Abstract] [Full Text] [Related]
50. Testosterone use for hypoactive sexual desire disorder in postmenopausal women.
Parish SJ; Kling JM
Menopause; 2023 Jul; 30(7):781-783. PubMed ID: 37314872
[TBL] [Abstract][Full Text] [Related]
51. Androgen use for low sexual desire in midlife women.
Davis SR
Menopause; 2013 Jul; 20(7):795-7. PubMed ID: 23632653
[TBL] [Abstract][Full Text] [Related]
52. Potential testosterone therapy for hypogonadal sexual dysfunction in women.
Simpkins JW; Van Meter R
J Womens Health (Larchmt); 2005 Jun; 14(5):449-51. PubMed ID: 15989418
[No Abstract] [Full Text] [Related]
53. Assessment and management of women's sexual dysfunctions: problematic desire and arousal.
Basson R; Brotto LA; Laan E; Redmond G; Utian WH
J Sex Med; 2005 May; 2(3):291-300. PubMed ID: 16422860
[TBL] [Abstract][Full Text] [Related]
54. Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause.
Ribera Torres L; Anglès-Acedo S; López Chardi L; Mension Coll E; Castelo-Branco C
Gynecol Endocrinol; 2024 Dec; 40(1):2364220. PubMed ID: 38913119
[TBL] [Abstract][Full Text] [Related]
55. The safety of testosterone therapy in women.
Al-Imari L; Wolfman WL
J Obstet Gynaecol Can; 2012 Sep; 34(9):859-865. PubMed ID: 22971455
[TBL] [Abstract][Full Text] [Related]
56. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.
Clayton AH; Althof SE; Kingsberg S; DeRogatis LR; Kroll R; Goldstein I; Kaminetsky J; Spana C; Lucas J; Jordan R; Portman DJ
Womens Health (Lond); 2016 Jun; 12(3):325-37. PubMed ID: 27181790
[TBL] [Abstract][Full Text] [Related]
57. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M; Rahman F; Puri LI; Rubin RS
Int J Impot Res; 2022 Nov; 34(7):635-641. PubMed ID: 36198811
[TBL] [Abstract][Full Text] [Related]
58. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
59. To be or not to be in sexual desire: the androgen dilemma.
Nappi RE
Climacteric; 2015 Oct; 18(5):672-4. PubMed ID: 26176767
[TBL] [Abstract][Full Text] [Related]
60. [Hypoactive sexual desire and testosterone deficiency in men].
Lejeune H; Huyghe É; Droupy S
Prog Urol; 2013 Jul; 23(9):621-8. PubMed ID: 23830256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
